Table 1. Patients' characteristics at baseline.
| Characteristics | n=12 |
|---|---|
| Age (years, mean ± SD) | 61 ± 10 |
| Gender (male/female, n) | 5/7 |
| Weight (kg, mean ± SD) | 84 ± 28 |
| Height (m, mean ± SD) | 1.72 ± 0.10 |
| BMI (kg/m2 , mean ± SD) | 27.8 ± 6.4 |
| HLA-AB mismatch (mean ± SD) | 2.1 ± 1.4 |
| HLA-DR mismatch (mean ± SD) | 0.9 ± 0.5 |
| Time after transplantation (years, median range) | 3 (1-38) |
| LD/DD (n) | 8/4 |
| Everolimus dose (mg/day, mean ± SD) | 2.5 ± 1.0 |
| Treated with MPA (n) | 11/12 |
| Prednisolone dose (mg/day, mean ± SD) | 4.6 ± 1.0 |
| Fluvastatin dose (mg/day, mean ± SD) | 80 ± 0.0 |
| P-creatinine (μmol/L, mean ± SD) | 104 ± 36 |
BMI, body mass index; LD, living donor; DD, deceased donor; HLA, human leucocyte antigen; MPA, mycophenolate acid.